Health Technology
Austrian companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Novo Nordisk A/S Class B dominates trading volume, whereas Becton, Dickinson and Company logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYCEli Lilly and Company | 1.19 T EUR | 1,222.4 EUR | −2.71% | 0 | 0.00 | 45.49 | 26.87 EUR | +55.94% | 0.47% | Strong buy |
 JNJJohnson & Johnson | 592.45 B EUR | 244.80 EUR | −0.59% | 5 | 0.12 | 42.07 | 5.82 EUR | −34.10% | 1.91% | Buy |
 ABBVAbbVie, Inc. | 464.16 B EUR | 259.6 EUR | −1.29% | 0 | 0.00 | 50.61 | 5.13 EUR | +354.14% | 2.35% | Buy |
 ROGPRoche Holding Ltd | 343.88 B EUR | 419 EUR | −1.87% | 0 | 0.00 | 25.24 | 16.60 EUR | +32.10% | 2.48% | Buy |
| ROGHRoche Holding Ltd | 343.88 B EUR | 427.0 EUR | −1.93% | 0 | 0.00 | 25.72 | 16.60 EUR | +32.10% | 2.69% | Buy |
 MRKMerck & Co., Inc. | 330.4 B EUR | 131.62 EUR | −1.78% | 0 | 0.00 | 152.27 | 0.86 EUR | −86.58% | 2.26% | Buy |
 NOVNNovartis AG | 267.8 B EUR | 143.02 EUR | −1.72% | 0 | 0.00 | 32.64 | 4.38 EUR | −33.91% | 2.76% | Neutral |
 TMOFThermo Fisher Scientific Inc. | 233.03 B EUR | 618.4 EUR | −0.29% | 0 | 0.00 | 36.96 | 16.73 EUR | +13.44% | 0.26% | Buy |
 AMGNAmgen Inc. | 230.4 B EUR | 413.60 EUR | −0.86% | 0 | 0.00 | 27.18 | 15.22 EUR | +38.07% | 2.08% | Neutral |
 GILDGilead Sciences, Inc. | 192.75 B EUR | 150.26 EUR | −1.83% | 25 | 0.28 | — | −2.78 EUR | −150.52% | 1.86% | Buy |
 ABTAbbott Laboratories | 178.02 B EUR | 99.56 EUR | −1.91% | 0 | 0.00 | 41.64 | 2.39 EUR | −64.81% | 2.18% | Buy |
 NNO2Novo Nordisk A/S Class B | 168.68 B EUR | 36.145 EUR | +0.25% | 2.9 K | 0.50 | 10.63 | 3.40 EUR | +9.26% | 4.10% | Neutral |
 PFEPfizer Inc. | 156.31 B EUR | 26.315 EUR | −3.11% | 157 | 0.11 | 42.64 | 0.62 EUR | −57.78% | 5.59% | Neutral |
 ISRGIntuitive Surgical, Inc. | 148.84 B EUR | 410.95 EUR | −4.69% | 0 | 0.00 | 56.33 | 7.30 EUR | +13.32% | 0.00% | Buy |
 DHRCDanaher Corporation | 147.21 B EUR | 204.6 EUR | −0.49% | 0 | 0.00 | 37.95 | 5.39 EUR | +30.20% | 0.65% | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 123.98 B EUR | 489.90 EUR | +1.52% | 0 | 0.00 | 35.70 | 13.72 EUR | +13.49% | 0.00% | Buy |
 MDTMedtronic Plc | 119.58 B EUR | 91.84 EUR | −1.18% | 100 | 0.91 | 26.05 | 3.53 EUR | +11.12% | 2.72% | Buy |
 BMYSBristol-Myers Squibb Company | 116.86 B EUR | 56.03 EUR | −1.67% | 0 | 0.00 | 14.06 | 3.98 EUR | +57.85% | 3.93% | Buy |
 SYKStryker Corporation | 115.16 B EUR | 292.6 EUR | −5.03% | 0 | 0.00 | 35.31 | 8.29 EUR | +27.68% | 1.04% | Buy |
 SANOSanofi SA | 100.88 B EUR | 80.98 EUR | −6.20% | 2 | 0.00 | 24.32 | 3.33 EUR | −35.60% | 4.90% | Buy |
 MRNAModerna, Inc. | 91.88 B EUR | 234.25 EUR | +6.65% | 133 | 0.69 | — | −6.99 EUR | −9.55% | 0.00% | Neutral |
 EIEssilorLuxottica SA | 87.56 B EUR | 193.85 EUR | +1.31% | 166 | 0.16 | 36.22 | 5.35 EUR | +3.83% | 2.12% | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 85.73 B EUR | 807.3 EUR | −1.67% | 0 | 0.00 | 20.19 | 39.99 EUR | +12.33% | 0.40% | Buy |
 MRCKMerck KGaA | 65.41 B EUR | 145.00 EUR | −4.98% | 0 | 0.00 | 26.60 | 5.45 EUR | −17.22% | 1.46% | Buy |
 BSXCBoston Scientific Corporation | 59.15 B EUR | 38.775 EUR | −2.82% | 1 | 0.01 | 18.60 | 2.09 EUR | +30.86% | 0.00% | Buy |
 TKDTakeda Pharmaceutical Co. Ltd. | 59.1 B EUR | 37.42 EUR | −3.16% | 0 | — | 318.28 | 0.12 EUR | +2.11% | 3.07% | Buy |
 UCBUCB S.A. | 53.69 B EUR | 282.4 EUR | −1.05% | 0 | 0.00 | 24.98 | 11.31 EUR | +64.98% | 0.36% | Buy |
 BAYNBayer AG | 53.29 B EUR | 54.50 EUR | −3.16% | 967 | 0.29 | — | −1.77 EUR | +49.15% | 0.20% | Buy |
 ARGXargenx SE | 51.25 B EUR | 796.2 EUR | −3.72% | 0 | 0.00 | 35.36 | 22.51 EUR | +24.40% | 0.00% | Strong buy |
 EWLSEdwards Lifesciences Corporation | 51.01 B EUR | 90.30 EUR | +0.49% | 0 | 0.00 | 61.20 | 1.48 EUR | +18.67% | 0.00% | Buy |
 BDXBecton, Dickinson and Company | 50.75 B EUR | 191.70 EUR | +8.34% | 0 | 0.00 | 66.04 | 2.90 EUR | −38.51% | 2.01% | Buy |
 SHLSiemens Healthineers AG | 50.04 B EUR | 43.96 EUR | −0.14% | 0 | 0.00 | 22.27 | 1.97 EUR | +2.35% | 2.23% | Buy |
 GALDGalderma Group AG | 49.43 B EUR | 210 EUR | −1.87% | 0 | 0.00 | 66.76 | 3.15 EUR | +113.32% | 0.18% | Buy |
 LONNLonza Group AG | 49.13 B EUR | 715.6 EUR | −2.00% | 0 | 0.00 | — | −1.68 EUR | −115.37% | 0.76% | Buy |
 IDXXIDEXX Laboratories, Inc. | 49.02 B EUR | 604.8 EUR | −3.48% | 0 | 0.00 | 46.18 | 13.10 EUR | +21.83% | 0.00% | Buy |
 AGILAgilent Technologies, Inc. | 44.49 B EUR | 156.20 EUR | +0.19% | 0 | 0.00 | 35.43 | 4.41 EUR | +18.01% | 0.58% | Buy |
 WTRSWaters Corporation | 40.92 B EUR | 413.8 EUR | +1.32% | 0 | 0.00 | 201.35 | 2.06 EUR | −77.83% | 0.00% | Buy |
 SDZSandoz Group Ltd | 39.38 B EUR | 90.28 EUR | −0.62% | 0 | 0.00 | 70.79 | 1.28 EUR | +169.78% | 0.97% | Neutral |
 IQVHIQVIA Holdings Inc | 38.72 B EUR | 241.9 EUR | +2.28% | 0 | 0.00 | 33.30 | 7.26 EUR | +17.03% | 0.00% | Strong buy |
 ALCAlcon AG | 34.46 B EUR | 66.46 EUR | −2.69% | 0 | — | 59.18 | 1.12 EUR | −44.23% | 0.44% | Buy |
 BIIBBiogen Inc. | 33.5 B EUR | 222.00 EUR | −1.07% | 0 | 0.00 | 107.66 | 2.06 EUR | −77.93% | 0.00% | Buy |
 ZOTSZoetis, Inc. Class A | 32.83 B EUR | 71.44 EUR | −9.02% | 0 | 0.00 | 13.42 | 5.32 EUR | +7.88% | 2.38% | Neutral |
 MTDMettler-Toledo International Inc. | 30.75 B EUR | 1,560 EUR | +3.04% | 0 | 0.00 | 40.10 | 38.90 EUR | +16.08% | 0.00% | Neutral |
 ILMNIllumina, Inc. | 30.51 B EUR | 189.98 EUR | −6.02% | 0 | 0.00 | 36.98 | 5.14 EUR | +35.08% | 0.00% | Buy |
 RMDResMed Inc. | 30.13 B EUR | 210.7 EUR | −3.70% | 0 | 0.00 | 21.74 | 9.69 EUR | +16.41% | 1.02% | Buy |
 DXCMDexCom, Inc. | 29.39 B EUR | 72.4 EUR | −9.95% | 0 | — | 32.15 | 2.25 EUR | +47.09% | 0.00% | Strong buy |
 GMABGenmab A/S | 28.53 B EUR | 472.9 EUR | −2.27% | 0 | 0.00 | 43.71 | 10.82 EUR | −40.96% | 0.00% | Buy |
 DIMSartorius Stedim Biotech SA | 21.76 B EUR | 222.6 EUR | −2.54% | 0 | — | 66.87 | 3.33 EUR | +22.74% | 0.31% | Strong buy |
 VTRSViatris, Inc. | 19.66 B EUR | 17.372 EUR | +1.56% | 0 | 0.00 | — | −0.31 EUR | +87.33% | 2.50% | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 19.22 B EUR | 141.20 EUR | −5.36% | 0 | 0.00 | 8.08 | 17.48 EUR | +8,430.94% | 0.00% | Buy |
 ZBHZimmer Biomet Holdings, Inc. | 18.71 B EUR | 95.00 EUR | −4.08% | 0 | 0.00 | 27.26 | 3.48 EUR | +1.19% | 0.87% | Neutral |
 STMNStraumann Holding AG | 18.66 B EUR | 113 EUR | −2.59% | 0 | 0.00 | 45.09 | 2.51 EUR | −4.77% | 0.93% | Buy |
 SOONSonova Holding AG | 18.17 B EUR | 311.1 EUR | −2.45% | 0 | — | 39.78 | 7.82 EUR | −17.15% | 1.62% | Neutral |
| SATGSartorius AG | 17.83 B EUR | 223.5 EUR | −3.25% | 0 | — | 70.67 | 3.16 EUR | +63.32% | 0.32% | Buy |
 COLOColoplast A/S Class B | 15.69 B EUR | 68.14 EUR | −2.18% | 0 | 0.00 | 37.43 | 1.82 EUR | −15.56% | 4.40% | Neutral |
 IPNIpsen SA | 12.89 B EUR | 154.0 EUR | −2.72% | 0 | 0.00 | 24.92 | 6.18 EUR | +15.12% | 1.03% | Neutral |
 BAXBaxter International Inc. | 12.21 B EUR | 22.85 EUR | −5.03% | 0 | 0.00 | — | −1.22 EUR | −174.16% | 0.15% | Neutral |
 BIMbioMerieux SA | 11.53 B EUR | 92.25 EUR | −3.25% | 0 | — | 23.65 | 3.90 EUR | +22.76% | 1.00% | Neutral |
 RECRecordati S.p.A. | 10.96 B EUR | 53.05 EUR | −0.28% | 0 | — | 22.29 | 2.38 EUR | +22.24% | 2.52% | Neutral |
 ALGNAlign Technology, Inc. | 10.43 B EUR | 146.25 EUR | −1.25% | 0 | — | 24.08 | 6.07 EUR | +38.11% | 0.00% | Buy |
 DEMADemant A/S | 10.27 B EUR | 50.50 EUR | −0.20% | 0 | — | 49.08 | 1.03 EUR | −28.80% | 0.00% | Buy |
 BMRNBioMarin Pharmaceutical Inc. | 9.86 B EUR | 49.98 EUR | −1.50% | 4 | 0.01 | — | −0.09 EUR | −104.02% | 0.00% | Buy |
 AVTRAvantor, Inc. | 9.45 B EUR | 13.810 EUR | −0.40% | 0 | — | 31.54 | 0.44 EUR | — | 0.00% | Neutral |
 QGE4QIAGEN NV | 9.35 B EUR | 45.2 EUR | −0.44% | 2 | 0.05 | 26.22 | 1.72 EUR | +12.91% | 0.69% | Neutral |
 KRKGKrka, d. d., Novo mesto | 7.73 B EUR | 247.5 EUR | −0.60% | 0 | — | 17.98 | 13.77 EUR | +10.70% | 3.67% | Buy |
 ALKBALK-abello A/S Class B | 7.24 B EUR | 32.52 EUR | −1.63% | 0 | — | 39.83 | 0.82 EUR | +35.40% | 0.66% | Strong buy |
 LUNAH. Lundbeck A/S Class A | 7.13 B EUR | 6.92 EUR | +1.17% | 0 | 0.00 | 13.26 | 0.52 EUR | +11.06% | 2.27% | No rating |
| LUNBH. Lundbeck A/S Class B | 7.13 B EUR | 7.500 EUR | +0.47% | 0 | 0.00 | 14.37 | 0.52 EUR | +11.06% | 2.10% | Buy |
 ABVXAbivax SA | 6.96 B EUR | 75.65 EUR | −6.83% | 3 | 0.75 | — | −5.23 EUR | −59.53% | 0.00% | Strong buy |
 GRFGrifols, S.A. Class A | 6.67 B EUR | 10.995 EUR | −3.00% | 0 | — | 16.54 | 0.66 EUR | +51.93% | 1.68% | Buy |
 DIASDiaSorin S.p.A. | 4.43 B EUR | 81.56 EUR | −1.43% | 0 | 0.00 | 30.85 | 2.64 EUR | −23.38% | 1.58% | Neutral |
 SFZNSiegfried Holding AG | 3.68 B EUR | 78.50 EUR | −2.91% | 0 | — | 18.53 | 4.24 EUR | +12.47% | 0.53% | Buy |
 1SXPSCHOTT Pharma AG & Co. KGaA | 3.52 B EUR | 21.65 EUR | −5.04% | 0 | — | 23.88 | 0.91 EUR | −7.01% | 0.77% | Buy |
 FIEFielmann Group AG | 3.48 B EUR | 42.80 EUR | +0.23% | 0 | — | 16.97 | 2.52 EUR | +24.89% | 3.38% | Buy |
 TECNTecan Group AG | 3.42 B EUR | 282.0 EUR | −3.56% | 0 | 0.00 | — | −9.92 EUR | −287.20% | 1.23% | Buy |
 ROVILaboratorios Farmaceuticos Rovi, S.A. | 3.22 B EUR | 67.65 EUR | −2.87% | 0 | — | 18.68 | 3.62 EUR | +39.34% | 1.22% | Buy |
 AFXCarl Zeiss Meditec AG | 3.2 B EUR | 33.90 EUR | −6.20% | 0 | — | 31.28 | 1.08 EUR | −38.81% | 1.54% | Sell |
 OBCKOttobock SE & Co. KGaA | 3.1 B EUR | 47.60 EUR | −2.76% | 0 | 0.00 | 23.69 | 2.01 EUR | — | 2.00% | Strong buy |
 AMBUAmbu A/S Class B | 3.04 B EUR | 11.74 EUR | −2.33% | 0 | — | 46.05 | 0.25 EUR | +41.47% | 0.48% | Neutral |
 BAVABavarian Nordic A/S | 2.61 B EUR | 32.50 EUR | −1.28% | 1 | — | 12.18 | 2.67 EUR | +9.77% | 0.00% | Strong buy |
 ALMAlmirall SA | 2.42 B EUR | 11.10 EUR | −1.77% | 0 | — | 40.51 | 0.27 EUR | — | 1.36% | Buy |
 ZEALZealand Pharma A/S | 2.1 B EUR | 31.20 EUR | −1.61% | 0 | 0.00 | 6.05 | 5.16 EUR | −58.53% | 0.00% | Buy |
 LKFTLakefront Biotherapeutics | 1.96 B EUR | 29.08 EUR | −4.22% | 0 | — | 3.21 | 9.05 EUR | — | 0.00% | Buy |
 DMPDermapharm Holding SE | 1.93 B EUR | 37.85 EUR | −2.70% | 0 | — | 13.72 | 2.76 EUR | +38.58% | 2.26% | Buy |
 XRAYDENTSPLY SIRONA, Inc. | 1.89 B EUR | 8.572 EUR | −6.07% | 0 | 0.00 | — | −2.40 EUR | +40.51% | 3.00% | Neutral |
 DRW8Draegerwerk AG & Co. KGaA | 1.72 B EUR | 77.0 EUR | −2.78% | 0 | — | 8.51 | 9.04 EUR | +40.18% | 2.80% | Buy |
 NVAXNovavax, Inc. | 1.56 B EUR | 9.50 EUR | +2.26% | 5 | 0.02 | — | −1.33 EUR | −169.59% | 0.00% | Buy |
 PHMPharma Mar SA | 1.19 B EUR | 66.85 EUR | 0.00% | 0 | — | 17.06 | 3.92 EUR | +102.78% | 1.21% | Buy |
 COPNCosmo N.V. | 1.1 B EUR | 61.5 EUR | −5.53% | 7 | 0.69 | — | −0.38 EUR | −111.41% | 3.22% | Strong buy |
 EUZGEckert & Ziegler SE | 876.04 M EUR | 13.59 EUR | −4.63% | 0 | — | 17.18 | 0.79 EUR | +35.27% | 1.57% | Strong buy |
 VLAValneva SE | 481.73 M EUR | 2.467 EUR | −4.19% | 538 | 0.74 | — | −0.90 EUR | −117.39% | 0.00% | Strong buy |
 FYBFormycon AG | 330.13 M EUR | 14.08 EUR | −21.69% | 0 | 0.00 | — | −1.42 EUR | +85.20% | 0.00% | Strong buy |
 SBSGSTRATEC SE | 310.58 M EUR | 25.05 EUR | −3.28% | 0 | — | — | −0.03 EUR | −103.25% | 2.35% | Buy |
 HPHAHeidelberg Pharma AG | 94.04 M EUR | 2.08 EUR | +2.46% | 0 | 0.00 | — | −0.64 EUR | −13.94% | 0.00% | Strong buy |
 PTPNPentixapharm Holding AG | 67.66 M EUR | 1.905 EUR | −4.75% | 355 | 975,816,569,651,200.00 | — | — | — | 0.00% | Strong buy |
 BIOBiogena Group Invest AG | — | 4.86 EUR | −0.41% | 297 | 0.19 | — | — | — | — | No rating |
 GHCGallmetzer Healthcare SpA | — | 3.40 EUR | 0.00% | 0 | 0.00 | — | — | — | — | Strong buy |